Barclays PLC Vanda Pharmaceuticals Inc. Call Options Transaction History

Barclays PLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2019 Nov 14, 2019	BUY	$12.27 - $15.79 $8,589 - $11,053	700 Added 70.0%	1,700 $23,000
Q3 2018 Nov 14, 2018	BUY	$18.25 - $23.0 $16,425 - $20,700	900 Added 900.0%	1,000 $23,000
Q2 2018 Aug 14, 2018	SELL	$13.95 - $19.15 $36,270 - $49,789	-2,600 Reduced 96.3%	100 $2,000
Q1 2018 May 15, 2018	SELL	$14.05 - $20.2 $46,365 - $66,660	-3,300 Reduced 55.0%	2,700 $45,000
Q4 2017 Feb 14, 2018	SELL	$12.85 - $18.1 $12,850 - $18,100	-1,000 Reduced 14.29%	6,000 $91,000
Q3 2017 Nov 14, 2017	BUY	$15.4 - $18.85 $107,800 - $131,950	7,000	7,000 $125,000

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $273M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.